←
Open Medicine Insights4,356 posts
Open Medicine Insights avatar✓

Open Medicine Insights ✓

@OpenMedInsights

Open access and free for everyone.

◷ Joined November 2012▧ 600 Photos and videos
Open Medicine Insights avatar
Open Medicine Insights@OpenMedInsights·22h

· Open Medicine Algorithm Spotlight · Hypernatremia Diagnostic Evaluation: Stepwise Clinical and Laboratory Approach (by @iamnephrologist) @OpenMedicineHQ Key points: - Concordance among sodium, measured osmolality, glucose, and measurement method distinguishes true hypertonic hypernatremia from analytical or osmolar discordance. - Neurologic findings reflect the severity and rapidity of hypertonicity, while hemodynamic and physical findings determine whether urgent volume resuscitation is required. - Classification as hypovolemic, euvolemic, or hypervolemic is a standard organizing step that narrows the balance of total-body water and sodium. ** Hypovolemic hypernatremia reflects combined sodium and water loss with proportionally greater water loss; orthostasis, tachycardia, low venous pressure, and prerenal kidney injury are supportive. ** Euvolemic hypernatremia usually represents relatively pure water loss through renal or extrarenal routes without clinically apparent sodium depletion or overload. ** Volume overload accompanying hypernatremia should prompt evaluation for hypertonic sodium administration, ingestion, dialysis-related loading, or less commonly mineralocorticoid-mediated retention. LIVING algorithm link: myopenmedicine.com/algorithm… #OpenMedicine #Nephrology #NephTwitter #KidneyDisease #NephPearls #InternalMedicine @OpenMedKate @scserendipity1

Open Medicine Insights avatar
Open Medicine Insights@OpenMedInsights·Nov 16

· Open Medicine Algorithm Spotlight · Clinical Decision-Making for Obinutuzumab in Glomerular Disease (@iamnephrologist) | @OpenMedicineHQ Key points: - Regulatory status and evidence differ substantially by disease: primary MN, active LN, and childhood-onset FRNS/SDNS are approved, whereas AAV and other glomerulopathies remain off-label. - Confirm active immune-mediated disease and obtain CBC with differential and platelets, serum creatinine/eGFR, liver tests, quantitative immunoglobulins, HBsAg and anti-HBc. - Active Immune Disease Likely to Benefit From B-Cell Depletion? B-cell depletion should be reserved for an appropriate immune-mediated diagnosis with potentially reversible activity rather than isolated chronic scarring or nonimmune proteinuria. - No—chronic scarring or alternative cause: Do Not Initiate Obinutuzumab; Treat Barrier or Redirect. LIVING algorithm link:myopenmedicine.com/algorithm… #OpenMedicine #Nephrology #NephTwitter #KidneyDisease #NephPearls @OpenMedKate @scserendipity1

Simon C avatar
⟳ Open Medicine Insights retweeted
Simon C@scserendipity1·Nov 14

Well said! One of the real joys of the past year in building a new company, Open Medicine, has been getting to work with new people who are already becoming good friends. Ashish really encompasses all we are trying to do. Collegiate, engaging, smart, innovative global and a lot of fun! Well done my friend! Richly deserved! @OpenMedKate @OpenMedInsights @AndreaNecchi @PGrivasMDPhD @GIMedOnc @TylerSbrt @AlisonBirtle @ProfSyedHussain @Prof_Nick_James